$1.65
0.03[1.85%]
At close: Apr 18
$1.65
0[0.00%]
After Hours: 7:38PM EDT
Lexicon Pharmaceuticals
(NASDAQ:LXRX)Lexicon Pharmaceuticals Stock (NASDAQ:LXRX), Analyst Ratings, Price Targets, Predictions
Lexicon Pharmaceuticals Inc has a consensus price target of $5.25, established from looking at the 7 latest analyst ratings. The last 3 analyst ratings were released from Needham, Citigroup, and Needham on April 11, 2024, May 31, 2023, and May 30, 2023. With an average price target of $2.67 between Needham, Citigroup, and Needham, there's an implied 61.62% upside for Lexicon Pharmaceuticals Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Needham
Citigroup
Jefferies
Piper Sandler
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Lexicon Pharmaceuticals
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/11/2024 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.65 | — | Needham | Joseph Stringer | — | Reiterates | → Hold | Get Alert |
| 05/31/2023 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.65 | 384.85% | Citigroup | Yigal Nochomovitz | $6 → $8 | Maintains | Buy | Get Alert |
| 05/30/2023 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.65 | — | Needham | Joseph Stringer | — | Maintains | Hold | Get Alert |
| 03/07/2023 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.65 | 81.82% | Jefferies | Andrew Tsai | → $3 | Initiates | → Hold | Get Alert |
| 11/22/2022 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.65 | 263.64% | Citigroup | Yigal Nochomovitz | $16 → $6 | Maintains | Buy | Get Alert |
| 08/12/2022 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.65 | 506.06% | Piper Sandler | Yasmeen Rahimi | → $10 | Initiates | → Overweight | Get Alert |
| 07/01/2022 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.65 | 1112.12% | Citigroup | Yigal Nochomovitz | $18 → $20 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Lexicon Pharmaceuticals (LXRX)?
The latest price target for Lexicon Pharmaceuticals (NASDAQ: LXRX) was reported by Needham on April 11, 2024. The analyst firm set a price target for $0.00 expecting LXRX to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Lexicon Pharmaceuticals (LXRX)?
The latest analyst rating for Lexicon Pharmaceuticals (NASDAQ: LXRX) was provided by Needham, and Lexicon Pharmaceuticals reiterated their hold rating.
When was the last upgrade for Lexicon Pharmaceuticals (LXRX)?
There is no last upgrade for Lexicon Pharmaceuticals.
When was the last downgrade for Lexicon Pharmaceuticals (LXRX)?
There is no last downgrade for Lexicon Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Lexicon Pharmaceuticals (LXRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lexicon Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lexicon Pharmaceuticals was filed on April 11, 2024 so you should expect the next rating to be made available sometime around April 11, 2025.
Is the Analyst Rating Lexicon Pharmaceuticals (LXRX) correct?
While ratings are subjective and will change, the latest Lexicon Pharmaceuticals (LXRX) rating was a reiterated with a price target of $0.00 to $0.00. The current price Lexicon Pharmaceuticals (LXRX) is trading at is $1.65, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.